Literature DB >> 154

Influence of hematocrit, blood gas tensions, and pH on pressure-flow relations in the isolated canine lung.

D Bucens, M C Pain.   

Abstract

An isolated perfused canine lung preparation in which determinants of vascular caliber could be individually controlled was developed. The relation of pulmonary arterial (Pa), venous (PV), and alveolar (PA) pressures was such that Pa greater than PA greater than PV throughout the whole lung. The addition of isoprenaline to the perfusate abolished vascular reactivity. Once stability was reached, vascular cross-sectional area remained acceptably constant for 2.25 hours as judged by normalized conductance. The influence of perfusate hematocrit, blood gas tensions, and pH on pressure-flow relations was then studied in 15 isolated canine lungs. The hematocrit-vascular conductance relation was derived at constant perfusion pressure. Conductance varied linearly with hematocrit over a range of 16.5 to 89.5%. Mean pulmonary arterial blood gas tensions were: PO2 = 121 mm Hg, PCO2 = 28 mm Hg, and pH = 7.46. Acute respiratory acidosis (PO2 = 30 mm Hg, PCO2 = 81 mm Hg, pH = 7.17) and lactic acidosis and hypoxemia (PO2 = 32 mm Hg, PCO2 = 21 mm Hg, pH = 6.96) did not significantly alter this relation. Transformation of the conductance-hematocrit data indicated that hematocrit was the most important determinant of relative apparent viscosity of the blood. Both acute respiratory and lactic acidosis failed to significantly increase relative viscosity within the range of hematocrit usually found in secondary polycythemia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 154     DOI: 10.1161/01.res.37.5.588

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  10 in total

Review 1.  Management of diabetes and hyperglycemia in hospitals.

Authors:  Stephen Clement; Susan S Braithwaite; Michelle F Magee; Andrew Ahmann; Elizabeth P Smith; Rebecca G Schafer; Irl B Hirsch; Irl B Hirsh
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

2.  Euglycaemic diabetic ketoacidosis.

Authors:  J F Munro; I W Campbell; A C McCuish; L J Duncan
Journal:  Br Med J       Date:  1973-06-09

3.  Reducing hospital inpatient length of stay for patients with diabetes.

Authors:  D A Cavan; P Hamilton; J Everett; D Kerr
Journal:  Diabet Med       Date:  2001-02       Impact factor: 4.359

4.  Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study.

Authors:  M I Wiggam; M J O'Kane; R Harper; A B Atkinson; D R Hadden; E R Trimble; P M Bell
Journal:  Diabetes Care       Date:  1997-09       Impact factor: 19.112

Review 5.  Recent advances in the monitoring and management of diabetic ketoacidosis.

Authors:  T M Wallace; D R Matthews
Journal:  QJM       Date:  2004-12

Review 6.  Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association.

Authors:  Abbas E Kitabchi; Guillermo E Umpierrez; Mary Beth Murphy; Robert A Kreisberg
Journal:  Diabetes Care       Date:  2006-12       Impact factor: 19.112

7.  Point of care blood ketone testing of diabetic patients in the emergency department.

Authors:  Firat Bektas; Oktay Eray; Ramazan Sari; Halide Akbas
Journal:  Endocr Res       Date:  2004-08       Impact factor: 1.720

8.  Euglycaemic diabetic ketoacidosis: does it exist?

Authors:  D Jenkins; C F Close; A J Krentz; M Nattrass; A D Wright
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

9.  Evaluation of a bedside blood ketone sensor: the effects of acidosis, hyperglycaemia and acetoacetate on sensor performance.

Authors:  A S A Khan; J A Talbot; K L Tieszen; E A Gardener; J M Gibson; J P New
Journal:  Diabet Med       Date:  2004-07       Impact factor: 4.359

10.  Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis?

Authors:  Mae Sheikh-Ali; Brad S Karon; Ananda Basu; Yogish C Kudva; Lisa A Muller; Jia Xu; W Frederick Schwenk; John M Miles
Journal:  Diabetes Care       Date:  2008-01-09       Impact factor: 19.112

  10 in total
  1 in total

1.  Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation.

Authors:  Franco Valenza; Lorenzo Rosso; Silvia Coppola; Sara Froio; Alessandro Palleschi; Davide Tosi; Paolo Mendogni; Valentina Salice; Giulia M Ruggeri; Jacopo Fumagalli; Alessandro Villa; Mario Nosotti; Luigi Santambrogio; Luciano Gattinoni
Journal:  Transpl Int       Date:  2014-04-04       Impact factor: 3.782

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.